FOLH1 and nonpapillary renal cell carcinoma: Consistently with the studies included in this systematic review, Yin et al. reported a poor accuracy of PSMA-targeted PET/CT in patients with metastatic non-ccRCC, inferior to conventional imaging with CT and/or MRI [59].